Patents by Inventor Mario Reinhard Stegert

Mario Reinhard Stegert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING CANCER BY MODULATING MAMMALIAN STERILE 20-LIKE KINASE 3
    Publication number: 20130089538
    Abstract: The present invention relates to a method for modulating miRNA, said method being characterized in that a modulator of XRN1 is used. Also provided are uses of said method for therapeutical purposes, reagents therefore, as well as screening methods.
    Type: Application
    Filed: June 9, 2011
    Publication date: April 11, 2013
    Applicant: Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute forBiomedical Researh
    Inventors: Hauke Hermann Karl Cornils, Brian Arthur Hemmings, Mario Reinhard Stegert
  • Phosphorylated Ndr kinase
    Patent number: 8008452
    Abstract: The present invention relates to the phosphorylated form of nuclear serine/threonine protein kinase, designated nuclear, Dbf2-related kinase (Ndr), and provides assays and materials for identifying modulators thereof. The invention relates to the fields of molecular biology, chemistry, pharmacology, and screening technology.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: August 30, 2011
    Assignee: Novartis Forschungesstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
    Inventors: Samuel Joseph Bichsel, Brian Arthur Hemmings, Mario Reinhard Stegert, Rastislav Tamaskovic